Trust Company of the South’s AbbVie ABBV Stock Holding History

Trust Company of the South’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09M	Hold	8,322	–	–	0.29%	37
2026 Q1	$1.81M	Buy	8,322 +175	+2%	+$38.8K	0.29%	37
2025 Q4	$1.86M	Buy	8,147 +1,483	+22%	+$338K	0.3%	35
2025 Q3	$1.54M	Buy	6,664 +686	+11%	+$140K	0.26%	38
2025 Q2	$1.11M	Buy	5,978 +302	+5%	+$56.1K	0.2%	50
2025 Q1	$1.19M	Buy	5,676 +142	+3%	+$27.6K	0.25%	46
2024 Q4	$983K	Hold	5,534	–	–	0.2%	52
2024 Q3	$1.09M	Hold	5,534	–	–	0.23%	47
2024 Q2	$949K	Hold	5,534	–	–	0.22%	45
2024 Q1	$1.01M	Sell	5,534 -796	-13%	-$137K	0.23%	44
2023 Q4	$981K	Buy	+6,330	New	+$923K	0.26%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Trust Company of the South's ABBV Position: Q2 2026 in Review

Trust Company of the South held its AbbVie (ABBV) position steady in Q2 2026 at 8,322 shares worth $2.09M. The position accounts for 0.29% of the portfolio, ranked #37.

Trust Company of the South first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Trust Company of the South held 8,322 shares of AbbVie worth $2.09M as of Q2 2026.
Trust Company of the South left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.29% of Trust Company of the South's portfolio in Q2 2026, its #37 holding.
Trust Company of the South first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Trust Company of the South's 13F filing for Q2 2026, filed 1 Jul 2026.